Drug Trial Radar · NCT07927556
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of QLS1410 Tablets in Patients With Uncontrolled Hypertension Who Are Receiving One or More Background Drug Treatments
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
260
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Dec 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the efficacy and safety of multiple dose strengths of QLS1410 in patients with uncontrolled hypertension.
Conditions
- Uncontrolled Hypertension
Interventions
Dose 1 of QLS1410Drug
Patients will take oral tablets of QLS1410 once daily (QD) for 12 weeks
Dose 2 of QLS1410Drug
Patients will take oral tablets of QLS1410 once daily (QD) for 12 weeks.
Dose 3 of QLS1410Drug
Patients will take oral tablets of QLS1410 once daily (QD) for 12 weeks.
PlaceboDrug
Matching placebo tablet administered orally, once daily (QD).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary efficacy endpointTime frame: At week 12
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.